Building a Successful CBD Practice in Your Pharmacy

Page created by Rodney Barnes
 
CONTINUE READING
Building a Successful CBD Practice in Your Pharmacy
9/9/2021

           Building a Successful CBD
          Practice in Your Pharmacy
                                    ACPE # 0130‐9999‐21‐294‐L04‐P&T

                                                       D. H. John Kim, Pharm.D., FAARFM
                                 Compounding Pharmacist / Functional Medicine Specialist
                                     Robinson Drug & Compounding Center (Mendham, NJ)
                                                      Email: John@robinsondrugshop.com
                                                             Instagram: @dr.john.pharmd

1

    Financial Disclosure

       Dr. John Kim is an owner of Robinson Drug & Compounding Center in
        Mendham, NJ
       Chief Scientific Officer of Imbue Botanicals CBD Company

2

                                                                                                 1
Building a Successful CBD Practice in Your Pharmacy
9/9/2021

    BIO

        Graduated with Cum Laude at Ernest Mario School of Pharmacy – Rutgers, The
         State University of New Jersey
        Fellow in Anti-Aging and Functional/Regenerative Medicine (A4M) (FAARFM)
        Specializing in pharmaceutical and cosmetic formulation
        Hormone replacement therapy, pain management, vector borne illness,
         mycotoxin, autoimmune disorder, Phyto-cannabinoid medicine

3

    Objectives
    1.   Discuss History and Overview of Cannabis in pharmacy
    2. Differences among hemp, marijuana, and other cannabis derivatives
    3. What are the Chemical Substances in the Cannabis Sativa Plant and
    pharmacology of Cannabidiol (CBD)
    4. What type of forms of use do pharmacists have to know? - dosage
    forms and different modes of delivery
    5. Extraction Science - Ethanol Extraction VS CO2 Extraction
    6. Discuss the indication of uses (Common issues pharmacists see within
    the community)
    7. Finding the right dosage in CBD isolates vs. Full Spectrum Extract CBD
    8. How to choose the right CBD company and why this is so important?
    9. How to implement a successful CBD program in your pharmacy

4

                                                                                            2
Building a Successful CBD Practice in Your Pharmacy
9/9/2021

        HISTORY

5

    History of Cannabis sativa

       Earliest robust evidence of human cannabis use dates from the Copper Age
        (4600~3600 BCE in Moldovia, Romania, and Bulgaria) and Bronze Age (3400 ~
        3200 BCE in southeastern Europe

       First recorded medical use of cannabis – Emperor Shen Nong from 2700 BCE
            Transcribed in 2nd century CE in Shen Nong Ben Cao Jing – noting hallucinatory
             effects, appetite stimulation, tonic and anti-senility effect
       Ancient Egypt – cannabis used for vaginal contractions and ophthalmological
        condition
       Greek physician – Dioscorides – used cannabis for earache in 1st century CE

6

                                                                                                    3
Building a Successful CBD Practice in Your Pharmacy
9/9/2021

        History
       THC dominant cannabis found in Yanghai Tombs in Xinjiang, China (700 BCE)
            Chinese description of Cannabis
                  Male – Superior for fiber
                  Female – Superior for intoxication – indicating presence of THC
                   content
    Modern History
    -   Irish physician William O’Shaughnessy – learned about “gunjah” in India.
         -   Studied literature and described various preparation, evaluated its toxicity
             in animals and reported side effects
         -   Medical cannabis spread through Europe and North America
               -   1854 – The Dispensatory of the United States of America
               -   Over 100 scientific articles were published in Europe and the United
                   States about therapeutic value of cannabis
               -   Late 19th and early 20th Century – numerous pharmaceutical
                   companies marketed cannabis
               -   Merck, Bristol Myers Squibb, Parke Davis, and Eli Lilly

7

                                                                 Cannabis
                                                                 sativa

8

                                                                                                  4
Building a Successful CBD Practice in Your Pharmacy
9/9/2021

                                            Cannabis sativa L.
                                               Family Cannabaceae – Closest relative is Humulus which
                                                produces a female flower known as hops – widely used as a
                                                flavor and aroma ingredient of beer
                                               Medicinal compounds in cannabis are produced in trichomes,
                                                a glandular protuberances that grow on the leaves and
                                                flowers and less extent on the bracts and stems of female
                                                plants
                                                    Trichomes – Produce resin rich Phyto-cannabinoids and
                                                     terpenoids (provides a strong aroma, repels insects,
                                                     and potentially suppress other surrounding vegetation
                                                    Resin – provides antibiotic and antifungal properties
                                                     and protect against water loss
                                                    Anti-oxidant activity – helps to protect plants from
                                                     ultraviolet (UV) radiation and oxidative stress
                                                    Contains more than 160 cannabinoids (ie. CBD, THCA,
                                                     CBN, CBG, CBC, CBDV, THCV, Delta 8 and Delta 9, etc)
                                                    580 natural compounds have been identified in
                                                     cannabis
                                                    Still don’t know Little to nothing about
                                                     pharmacological effect for a lot of compounds in a
                                                     cannabis plant

9

     Cannabis sativa L.

        Chemical composition of plant will vary from:
             Environment
             Increased cannabinoid production associated with low humidity, sparse rainfall,
              increase UV radiation, soil nutrient (magnesium and iron) and parasites
             Soil microbiome (bacteria) – influences the quality of the plant
        Cannabis flowers can contain potential pathogenic microbes
             Several toxigenic fungi – Penicillium and Aspergillus species
             This can be detrimental to immunocompromised patients associated with cannabis
              inhalation
             Method of sterilization is developed
             Checking microbial testing on the finished cannabis/CBD product is a must

10

                                                                                                                   5
Building a Successful CBD Practice in Your Pharmacy
9/9/2021

                              Medical varieties of Cannabis
                                   Type 1 – THC dominant
                                   Type 2 – both THC and Cannabidiol (CBD)
                                   Type 3 – CBD Dominant

                              Recently – Hemp – grown for non-medical crops
     Cannabis Varieties        including fiber, herd (center of stalk) and seed
                                   Regulation of 0.3% (W/W) THC- content
                                   Type 3 CBD rich flowers with ultra low THC
                                    content – to be qualified as a hemp product

                              Strains of Cannabis
                                   Type 1 – Sativa
                                   Type 2 – Hybrid
                                   Type 3 – Indica

11

        Endocannabinoid
             System
         - Master system

12

                                                                                        6
Building a Successful CBD Practice in Your Pharmacy
9/9/2021

     Endocannabinoid
     System (ECS)
        Located in the mammalian central
         nervous system (brain and spinal cord)
         and peripheral nervous system (nerves
         / ganglia outside of the brain and spinal
         cord)
        Regulates various physiological and
         cognitive process – appetite, pain
         sensation, mood, fertility, pregnancy,
         during pre-and post-natal development,
         and in mediating the pharmacological
         effects of cannabis
        ECS – Consists of endocannabinoids,
         cannabinoid receptors and enzymes
         responsible for synthesis and
         degradation of endocannabinoids
             Anandamide (AEA)
             2-arachidonoyl glycerol (2-AG)

13

     ECS
        Harmony = Homeostasis and
         immune system – stability,
         balance, or equilibrium within a
         cell or the body
        Sense of bliss, joy, subsiding both
         physical and emotional pain
        CBD – Emotionally elevated –
         Enhances the quality of life
        Endocannabinoid System
        CB1 and CB2 Receptor – 2 main
         receptors (G-Protein Coupled
         Receptors (GPCR)
             CB1 – Located primarily in the
              CNS
             CB2 – Primarily
              immunomodulatory and found in
              periphery (i.e.. Organs)

14

                                                           7
Building a Successful CBD Practice in Your Pharmacy
9/9/2021

15

16

           8
Building a Successful CBD Practice in Your Pharmacy
9/9/2021

17

     ECS

        Both THC and CBD – compete to bind to the CB1 receptor
             THC – potential partial agonist and orthosteric binder – resulting in euphoria and
              other psychotropic effect
             CBD – Negative allosteric modulator – Alters the shape of the CB1 receptor and
              reduces binding ability of THC – i.e.. THC overdose – high concentrated CBD can be
              used in an emergency medicine setting
        Cannabinoids binding to receptors to produce agonist or antagonist response
             Agonist – cause euphoria, hunger, or thirst (cotton mouth)
             Antagonist – produce complete opposite response
                                                        DK1

18

                                                                                                         9
Building a Successful CBD Practice in Your Pharmacy
Slide 18

DK1   Dou Kim, 9/6/2021
9/9/2021

                                              Cannabidiol

19

     Cannabidiol (CBD)
        65 distinctive pharmacological
         target for cannabidiol (In Vitro
         studies) including receptors, ion
         channels, and enzymes, and
         transporters
        Strong pleotropic – many immune,
         physiological modulating activity
         exert by CBD
        Remarkably safe and well-
         tolerated
             Chronic use and high doses up
              to 1500mg/day of CBD are
              reportedly well-tolerated in
              humans

20

                                                                 10
9/9/2021

     Pharmacology of CBD

             Stimulation of serotonin 5-HT1A receptors – common mechanism for reducing anxiety,
              reduce the damage of brain ischemia, reducing nausea, and improve cognition In
              hepatic encephalopathy
                  Common MOA for anxiolytic and antidepressants for targeting 5-HT1A receptors
                  5-HT1A – Improves cognition, decreases aggression, increases sociability,
                   decreased impulsivity, inhibit drug seeking behavior, and facilitate sex drive and
                   arousal

             Adenosine receptors – Regulate heart function, inflammation, and dopamine and
              glutamate release in brain
                  CBD stimulates adenosine A1 receptor – this has been shown to prevent irregular
                   heart rhythm in rodent model of heart attack
                  Anti-inflammatory and potential neuroprotective effect

21

     Pharmacology of CBD
        Glycine receptor - Modulate neuropathic pain and inflammation
             Targeting alpha-glycine receptor to reduce chronic inflammatory pain caused by noxious
              heat stimulation
             Antispasmodic effect

        Dopamine Receptor – Partial agonist at the dopamine D2 receptor
             Antipsychotic effect at high doses in humans
                  Similar biphasic effects as dopamine partial agonist medication – aripiprazole

        GPR55 – anti-inflammatory effect – reduce neuronal excitability via GPR55
         antagonism
        Ion Channels – agonist at transient receptor potential vanilloid type 1 (TRPV1) –
         mechanism of analgesic, anti-inflammatory and anti-epileptic effects and
         contribute to its anti-psychotic effects
             Commonly used in topical preparation
             Voltage dependent anion selective channel 1 (VDAC1) – helps to modulate cellular
              energy, calcium homeostasis, apoptosis, and protection against oxidative stress

        Transporters and enzymes – CBD prevents reuptake of several neurotransmitters
         including norepinephrine, dopamine, serotonin, GABA, and anandamide

22

                                                                                                             11
9/9/2021

     Phytocannabinoid
     pharmacology
        Entourage Effect – Phyto
         cannabinoids (found in trace
         quantities) can produce
         synergistic pharmacological
         effects with well-known counter
         parts
        Phytoconstituent synergy is the
         rule of cannabis-derived
         medicine – Contributes to diverse
         therapeutic effect and potential
         clinical application

23

     Highlight of Entourage Effect

        Randomized controlled trial of patients with intractable pain
             Whole Plant extract (CBD and THC) vs synthetic THC
             Whole plant did better at pain control
        Animal model study – Full spectrum extract of cannabis (rich in CBD and other
         Cannabinoids and low in THC) – produced linear dose response
        Breast Cancer study – (tissue culture) – Combination of CBG and THCA showed
         better results treating the tumor compared to single THC extract

24

                                                                                              12
9/9/2021

     Terpene profile

25

     CBD
     Products

26

                            13
9/9/2021

     Available forms of
     CBD Products
        Full Spectrum – Provides the full
         entourage effect for a great
         synergistic therapeutical value to
         your CB1
        Broad Spectrum – THC removed
         (Ideal for clients getting drug
         tested)
        Isolate – Single cannabinoid (i.e..
         CBD, CBG, CBN, THCA, THCV,
         CBDV)

27

     Extraction Science

        CO2 Extraction vs Ethanol extraction – Main question to ask is what are you
         trying to produce?
        There is no perfect extraction method and there are advantages and
         disadvantages of both extraction process
        Ethanol Extraction – One of the oldest way of extracting – Record of ethanol-
         based cannabis tinctures being sold in apothecaries in the United States until
         1937 when cannabis was outlawed
        CO2 Extraction – Method invented by the Nazis to extracting oil from shale for
         the war. – Large scale CO2 has been repurposed for the beer industry to
         extract hops (relative of cannabis plant)

28

                                                                                               14
9/9/2021

        Extraction science
     CO2 Extraction                                             Ethanol Extraction
     Uses carbon dioxide – requires correct temperature and     Alcohol used as a solvent – cleanest and safest
     pressure conditions                                        solvents compared to butane
     Clean/Safe - CO2 is non-polar and non-water soluble        No residual residue present – ethanol is
                                                                completely and easily evaporated
     Very picky – Fails to extract much of the beneficial       Highly Efficient extraction – POLAR IN NATURE –
     phytochemicals present in cannabis resin (As a results –   bonds with water- and fat-soluble plant
     CO2 extraction requires ethanol use during final process   compounds including fatty acids, terpenes and
     to capture lost phytochemicals                             Phyto cannabinoids (Purifying hemp resin)

     Drastically changes chemical composition of cannabis       Excellent choice for full spectrum extract – Best
     strain – eliminates subtle flavor and aroma molecules      for producing hemp oil for health and wellness
     (due to different phase (liquid to gas) changes            purpose
     Produces a different product compared to ethanol           Pulls away all plant material – tend have darker
     extraction                                                 green color and more bitter taste
     Ideal for consumers looking for isolate cannabinoids or    Ethanol can be recirculated during extraction
     pure form of cannabinoids                                  process to ensure optimal extraction of essential
                                                                oil (Most efficient extraction)
     Light to dark amber in color – honey like texture          Dark amber coloration – syrupy in texture

29

                                                     Dosage
                                                     Form

30

                                                                                                                         15
9/9/2021

     Available Forms for Use
        Route of Administration:
             Tinctures – Use of carrier oil like MCT Oil, coconut oil, olive oil
                  When full spectrum oil Is mixed with carrier oil – the bitterness must be
                   masked
             Capsules – Slowest onset of delivery and must pass through 1st pass metabolism
              in the liver. Therapeutic effect is the longest
             Gummies – Provide both mucosal and gut absorption
             Topical Cream / Lotion / Ointment – This will provide local treatment for pain
              and dermatological issues
                  Systemic absorption is not possible
             Vapor Cartridges – Quickest on-set of delivery through the lungs into
              bloodstream
                  Potential issues dealing with volatile gas from propylene glycol or another
                   cutting agent

31

     Available dosage form

        Kief – Trichomes and terpenes are sifted through a fine mesh screens and yield
         collection of trichomes
             Usually these are raw form of flower and needs to be smoked, vaporized or
              decarboxylated to convert from CBDA to CBD
        Bubble Hash
             Using ice water – separate trichomes from the plant material
        Cannabis Concentrates – CBD flower resin – Concentrate of CBD and/or other
         cannabinoids are pressed with high pressure will separate the resin
             CBD Rosin

32

                                                                                                      16
9/9/2021

     Indications for
     CBD

33

      Indication

34

                            17
9/9/2021

     Indication
        Epilepsy and seizure disorders
             Studies since 1970s as anti-seizure and anti-epileptic compound
             FDA approved product – EPIDIOLEX – approved in 2018 – indicated for rare diseases for
              Dravet Syndrome and Lennox-Gastaut Syndrome (Childhood seizure disorder)
             Mechanism unknown – May act by modulating endogenous systems such as neuronal
              inhibition, intracellular calcium and adenosine modulation

        Sleep and Anxiety
             Large Case study – 79.2% (57 out of 72) of patients had decreased anxiety score and
              sleep complaints 66.7% patients (48 out of 72) had improved sleep in the first month
             Public Speaking – Reverse Anxiogenic effect of THC and reduced anxiety.
             May be used as an adjuvant in anxiety disorder
             PTSD – CBD shown to modulate fear memory formation through interaction with
              serotonergic Transmission in the mesolimbic system ( Norris et al. – Neuropsychology.
              (2016)- 41, 2839-2950

35

     Inflammation and Immune modulation

        Inflammation – Body’s own mechanism to stimulate immune response and
         designed to protect the body from disease
        Disruption of functionality leads into autoimmune disease – rheumatoid
         arthritis, lupus, celiac disease, and psoriatic arthritis
             CBD has been shown to balance and demonstrate immunosuppressive effect and
              shown to inhibit the formation of keratinocytes that are typical for psoriatic
              arthritis

36

                                                                                                           18
9/9/2021

     Cancer

        Cancer – gene mutation, cellular damage, immune mediated responses,
         inflammation
        Many cannabinoids (i.e.. CBD, CBG, CBN, THC) shown to have various anti-
         cancer characteristic including anti-proliferative, and pro-apoptotic
         properties
        Effects of CBD on numerous cancer cell lines (in-vivo and in-vitro)
             Breast carcinoma, prostate carcinoma, colorectal carcinoma, skin cancer,
              pancreatic cancer, lung cancer, and bone cancer
             Future – CBD could be used as an adjunctive therapy to target cancer cell lines
              which can ultimately reduce side effects many patients experience when
              undergoing chemotherapy and radiation treatment

37

     Neuroprotective and Neurodegerative
     Disease
        Alzheimer’s, Parkinson’s, and Huntington’s
        CBD has been shown to exert neuroprotective, anti-oxidative, and anti-apoptotic
         effects
             Shown to inhibit neurotoxicity of beta amyloid peptides in mouse models in vivo
                  Slowing progression of Alzheimer’s Disease
                  Shown to also decrease copper-zinc enzyme which can lead to additional signs of oxidative

        United States Department of Health and Human Services hold a patent titled –
         Cannabinoid as Antioxidants and Neuroprotectants

38

                                                                                                                    19
9/9/2021

                     Anticonvulsive

                     Antiinflammatory

     Conclusion:     Analgesic

                     Antioxidant
     Cannabidiol:    Antifibrotic
     Physiological   Anxiolytic

     Activity        Antipsychotic

                     Procognitive

                     Neuroprotective

39

                       Dosing on
                       CBD

40

                                             20
9/9/2021

     Dosing
                                Varies from product to product, type
                                 of extraction process used, where it
                                 has grown, how it is processed
                                CBD Isolate – Narrow therapeutic
                                 window (Bell Curve response when
                                 administered)
                                Full Spectrum – Tend to show direct
                                 response between dose increase (no
                                 upper limit or hitting a “response
                                 plateau”)
                                     Coming from the Entourage effect
                                     Full spectrum oil – Patients able to
                                      take higher dosage and titrate
                                      rapidly as risk of overshooting dose
                                      for therapeutic response is less.

                                Patients must go through a process
                                 of trial and error to find the correct
                                 dose
                                     Dose depended on the condition we
                                      are targeting for the patient

41

              How to market CBD into your
                     community?
42

                                                                                  21
9/9/2021

     Marketing: Healthcare Professionals

          Direct Marketing to Doctor’s Office – Find out who your local medical
           marijuana licensees are – Directly market to them first
               Cross hybridization of cannabis caused high yield of 9-delta-tetrahydrocannabidiol
                (THC) – Cause high side effects
          Pain specialists, Rheumatologist, Gastroenterologist, Neurologists,
           Functional/Integrative Specialists, Infectious Disease (treating vector borne
           illness)
          Know your science on CBD – Understanding of endocannabinoid system is very
           important
          Become the community highly sought after Phyto-cannabinoid specialist.

43

     Marketing: Patient/Support Group

           Patient seminar – Monthly
           Upselling CBD products to patients who are on opioids, SSRIs, compounded
            low dose naltrexone, immune modulators (i.e. Humira, Methotrexate) – CBD
            capsules /tinctures
           Any patients that are on topical eczema/psoriasis products – Recommend
            CBD Salves
           Beauty Cream
           Facebook support group – LDN (Low Dose Naltrexone) patient group page,
            Chronic Illness Page, etc.
           Instagram Page – Direct consumer education - @Dr.John.PharmD
           Online Retail Store

44

                                                                                                          22
9/9/2021

     Why Pharmacists Should Get Involved in
     Phyto-Cannabinoid Medicine
             Selecting right dosage form of Full Spectrum CBD (ie. Capsules, tinctures, salves,
              lotions, gummies and vapors) can be complex to consumers – Pharmacists should
              be in the forefront.
             Patients who seek hemp-based CBD products already suffer from complex
              conditions such as chronic pain, auto-immune disorders and other individualized
              aliments.
             Pharmacists are the most accessible healthcare professionals that can consult
              with the patient
             Pharmacists can work with patients and physicians to provide a triad-relationship
              to bring optimal therapeutic options along with compounded medications to
              better their overall health and wellness

45

     Why Pharmacists Should Get Involved

        If you are in the compounding business:
             Low Dose Naltrexone Therapy – Endorphin system is complimentary to the
              Endocannabinoid system – Enhances the effectiveness of CBD by the LDN – Seen in
              managing pain, autoimmune disorders, cancer, etc.

46

                                                                                                        23
9/9/2021

     What to look for in a CBD company

         Sourcing of high quality hemp – Where does the company grow their hemp?
          How is it grown? Organic? Sustainable growing process?
         Extraction process of hemp and testing of raw hemp (hemp is a bio-
          accumulator)
         Rigorous third-party testing to ensure potency (guaranteeing the strength and
          terpene profile) and it is safe for your patients (ie. heavy metal testing,
          solvent testing, microbial/mycotoxin testing, insecticides and other
          contaminants)
         Where do they manufacture their finished products? Who is their processing
          company? Are they “white labeling” their products?
         CBD company should be committed to delivering clinical-grade products that
          are sold by healthcare professionals
         Company does not produce or sell inhalable products
         Strong customer service and education support for wholesale customers
         Product development backed by science, innovation and research.

47

     Conclusion

      D. H. John Kim, Pharm.D., FAARFM
      Compounding Pharmacist / Functional Medicine
      Specialist
      Robinson Drug & Compounding Center (Mendham, NJ)
      Email: John@robinsondrugshop.com
      Instagram: @dr.john.pharmd

48

                                                                                               24
9/9/2021

     You Must Submit a Completed
     Evaluation Form for This Session
     to Receive CE Credit
     Please go online to https://www.surveymonkey.com/r/VFCHC9M and
     complete the short evaluation for this session.

     YOU HAVE 5 DAYS TO COMPLETE THE EVALUATION. THE EVALUATION
     LINK WILL DEACTIVATE AFTER 5 DAYS AND NO EVALUATIONS WILL BE
     ACCEPTED AFTER THAT TIME.

49

                                                                           25
You can also read